Joel D. Pearson
Impact in
-
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- Ubiquitin and proteasome pathways 2
- RNA Research and Splicing 2
- Oncology 6
- Cancer-related Molecular Pathways 3
- Cancer Cells and Metastasis 2
- Co-authors
- Robert J. Ingham (6 shared papers)James Koropatnick (2 shared papers)Raymond Lai (4 shared papers)Julinor Bacani (3 shared papers)Rod Bremner (7 shared papers)Jason K. H. Lee (2 shared papers)Daniel Schramek (2 shared papers)Yupo Ma (2 shared papers)
- Journals
- Cell Reports (1 paper)Blood Cancer Journal (1 paper)Molecular Pharmacology (1 paper)Oncogene (1 paper)Nature (1 paper)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Joel D. Pearson
15 papers receiving 338 citations
Peers
Comparison fields: 5 of 58
- Oncology 128
- Pathology and Forensic Medicine 48
- Cancer Research 40
- Pulmonary and Respiratory Medicine 83
- Ophthalmology 20
Countries citing papers authored by Joel D. Pearson
This map shows the geographic impact of Joel D. Pearson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joel D. Pearson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joel D. Pearson more than expected).
Fields of papers citing papers by Joel D. Pearson
This network shows the impact of papers produced by Joel D. Pearson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joel D. Pearson. The network helps show where Joel D. Pearson may publish in the future.
Co-authors
The 25 scholars most cited alongside Joel D. Pearson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 81 | |
| 2 | 2012 | 42 | |
| 3 | 2012 | 35 | |
| 4 | 2012 | 33 | |
| 5 | 2020 | 28 | |
| 6 | 1993 | 24 | |
| 7 | 1990 | 22 | |
| 8 | 2009 | 21 | |
| 9 | NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma. | 2011 | 20 |
| 10 | 2022 | 17 | |
| 11 | 2014 | 11 | |
| 12 | 2025 | 5 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 2 | |
| 15 | 2021 | 1 | |
| 16 | 2025 | 0 | |
| 17 | 2013 | 0 |
About Joel D. Pearson
Joel D. Pearson is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Immunology, having authored 17 papers that have together received 345 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Genomics and Diagnostics (2 papers), Ubiquitin and proteasome pathways (2 papers), Trace Elements in Health (2 papers), Cancer Cells and Metastasis (2 papers), RNA Research and Splicing (2 papers) and Hippo pathway signaling and YAP/TAZ (2 papers). The work is most often cited by research in Oncology (128 citations), Pathology and Forensic Medicine (48 citations), Cancer Research (40 citations), Pulmonary and Respiratory Medicine (83 citations) and Ophthalmology (20 citations). Joel D. Pearson has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Robert J. Ingham, James Koropatnick, Raymond Lai, Julinor Bacani, Rod Bremner, Jason K. H. Lee, Daniel Schramek, Yupo Ma, Agnieszka K. Witkiewicz and Vishnu Kumarasamy. Their work appears in journals such as Cell Reports, Blood Cancer Journal, Molecular Pharmacology, Oncogene and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.